Browse Articles
Discover research articles across all indexed journals
Reply to Y. Liang et al
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
PURPOSE Patients with IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma (O3 IDHmt/Codel ) benefit from adding alkylating agent chemotherapy to radiotherapy (RT). However, the optimal chemotherapy regimen between procarbazine, 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), and vincristine (PCV) and temozolomide (TMZ) remains unclear given the lack of randomized trial data comparing both regimens. METHODS The objective was to assess the overall survival (OS) and progression-free survival (PFS) associated with first-line PCV/RT versus TMZ/RT in patients newly diagnosed with O3 IDHmt/Codel . We included patients with histologically proven O3 IDHmt/Codel (according to WHO criteria) from the French national prospective cohort Prise en charge des OLigodendrogliomes Anaplasiques (POLA). All tumors underwent central pathologic review. OS and PFS from surgery were estimated using the Kaplan-Meier method and Cox regression model. RESULTS 305 newly diagnosed patients with O3 IDHmt/Codel treated with RT and chemotherapy between 2008 and 2022 were included, of which 67.9% of patients (n = 207) were treated with PCV/RT and 32.1% with TMZ/RT (n = 98). The median follow-up was 78.4 months (IQR, 44.3-102.7). The median OS was not reached (95% CI, Not reached [NR] to NR) in the PCV/RT group and was 140 months (95% CI, 110 to NR) in the TMZ/RT group (log-rank P = .0033). On univariable analysis, there was a significant difference in favor of PCV/RT in both 5-year (PCV/RT: 89%, 95% CI, 85 to 94; TMZ/RT: 75%, 95% CI, 66 to 84) and 10-year OS (PCV/RT: 72%, 95% CI, 61 to 85; TMZ/RT: 60%, 95% CI, 49 to 73), which was confirmed using the multivariable Cox model adjusted for age, type of surgery, gender, Eastern Cooperative Oncology Group performance status, and CDKN2A homozygous deletion (hazard ratio, 0.53 for PCV/RT, 95% CI, 0.30 to 0.92, P = .025). CONCLUSION In patients with newly diagnosed O3 IDHmt/Codel from the POLA cohort, first-line PCV/RT was associated with better OS outcomes compared with TMZ/RT. Our data suggest that the improved safety profile associated with TMZ comes at the cost of inferior efficacy in this population. Further investigation using prospective randomized studies is warranted.
Reply to P. de Boissieu et al
<i>UGT1A1</i> Testing for the Risk of Nanoliposomal Irinotecan–Related Toxicity
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
PURPOSE The value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncologic outcomes between bladder-only (BO)-RT and whole-pelvis (WP)-RT using a large Canadian multicenter collaborative database. PATIENTS AND METHODS The study cohort consisted of 809 patients with MIBC (cT2-4aN0-2M0) who underwent curative RT at academic centers across Canada. Patients were divided into two groups on the basis of the RT volume: WP-RT versus BO-RT. Inverse probability of treatment weighting (IPTW) and absolute standardized differences (ASDs) were used to balance covariates across treatment groups. Regression models were used to assess the effect of the RT volume on the rates of complete response (CR), cancer-specific survival (CSS), and overall survival (OS). RESULTS After exclusion criteria, 599 patients were included, of whom 369 (61.6%) underwent WP-RT. Patients receiving WP-RT were younger (ASD, 0.41) and more likely to have an Eastern Cooperative Oncology Group performance status of 0-1 (ASD, 0.21), clinical node-positive disease (ASD, 0.40), and lymphovascular invasion (ASD, 0.25). In addition, WP-RT patients were more commonly treated with neoadjuvant chemotherapy (ASD, 0.29) and concurrent chemotherapy (ASD, 0.44). In the IPTW cohort, BO-RT and WP-RT groups were well balanced (all pretreatment parameters with an ASD <0.10). In multivariable analysis, WP-RT was not associated with CR rates post-RT (odds ratio, 1.14 [95 CI, 0.76 to 1.72]; P = .526) but was associated with both CSS (hazard ratio [HR], 0.66 [95% CI, 0.47 to 0.93]; P = .016) and OS (HR, 0.68 [95% CI, 0.54 to 0.87]; P = .002), independent of other prognostic factors. CONCLUSION Our study demonstrated that WP radiation was associated with better survival compared with bladder radiation alone after adjusted analysis. Additional randomized controlled trials are needed to confirm our findings.
Misleading Reporting of a Negative Randomized Clinical Trial May Affect Clinical Practice
Advanced optical reinforcement materials based on three-dimensional four-way weaving structure and metasurface technology
By integrating the design principles of broadband metamaterial absorbers with woven structures, this study introduces a woven composite metamaterial (WCM) made of resin and AlCuFe quasicrystals, enabling optical materials to operate efficiently across a wide spectral range while withstanding mechanical deformation. This lightweight metamaterial features a unique 3D four-way braided structure combined with Dirac semimetals. Static analysis reveals that AlCuFe quasicrystals significantly enhance mechanical properties, with a Young's modulus reaching 38 GPa in the z direction and 18 GPa in the x and y directions at 40% fiber content and a 30° weaving angle. Frequency domain simulations show a high average absorption rate of 83.4% in the 3–12 μm range, primarily due to internal electromagnetic coupling. The study further reveals that the electromagnetic properties of the WCM are closely related to fiber content and weaving angle. As a lightweight optical material, the WCM shows strong application potential in fields such as aerospace and electromagnetic countermeasures.
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01
PURPOSE The global, phase 3, open-label, randomized TROPION-Breast01 study assessed the trophoblast cell surface antigen 2–directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd) versus investigator's choice of chemotherapy (ICC) in hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) breast cancer. METHODS Adult patients with inoperable/metastatic HR+/HER2‒ breast cancer, who had disease progression on endocrine therapy, for whom endocrine therapy was unsuitable, and had received one to two previous lines of chemotherapy in the inoperable/metastatic setting, were randomly assigned 1:1 to Dato-DXd (6 mg/kg once every 3 weeks) or ICC (eribulin/vinorelbine/capecitabine/gemcitabine). Dual primary end points were progression-free survival (PFS) by blinded independent central review (BICR) and overall survival (OS). RESULTS Patients were randomly assigned to Dato-DXd (n = 365) or ICC (n = 367). Dato-DXd significantly reduced the risk of progression or death versus ICC (PFS by BICR hazard ratio [HR], 0.63 [95% CI, 0.52 to 0.76]; P < .0001). Consistent PFS benefit was observed across subgroups. Although OS data were not mature, a trend favoring Dato-DXd was observed (HR, 0.84 [95% CI, 0.62 to 1.14]). The rate of grade ≥3 treatment-related adverse events (TRAEs) with Dato-DXd was lower than ICC (20.8% v 44.7%). The most common TRAEs (any grade; grade ≥3) were nausea (51.1%; 1.4%) and stomatitis (50%; 6.4%) with Dato-DXd and neutropenia (grouped term, 42.5%; 30.8%) with ICC. CONCLUSION Patients receiving Dato-DXd had statistically significant and clinically meaningful improvement in PFS and a favorable and manageable safety profile, compared with ICC. Results support Dato-DXd as a novel treatment option for patients with inoperable/metastatic HR+/HER2‒ breast cancer who have received one to two previous lines of chemotherapy in this setting.
A 780 nm optical frequency standard based on diffuse laser cooled 87Rb atoms
We demonstrate an optical frequency standard by locking the output frequency of an external cavity diode laser to the 780 nm D2 transition of diffuse laser cooled 87Rb atoms using frequency modulation spectroscopy (FMS). A 50-cm-long cold atomic cloud is obtained within a ϕ 2 cm ×l 50 cm vacuum glass tube, featuring greater simplicity and reliability. By analyzing the impact of power and detuning of cooling and repumping lasers, and power of frequency-modulated laser on FMS based on cold atoms, we choose the optimal parameter and lock the laser frequency to the 87Rb 52S1/2 (F = 2) → 52P3/2 (F′ = 3) cycling transition. The cold-atom-based optical frequency standard achieves an in-loop frequency stability of 3.3 × 10−15 at 1 s, with peak-to-peak frequency fluctuations being less than 50 Hz within 6000 s. This represents the integration of cold atoms into an optical frequency standard utilizing FMS for frequency stabilization. In contrast to the common cold-atom optical frequency standards, our approach requires fewer lasers and eliminates the need for a complex and expensive Pound–Drever–Hall (PDH) system. Its low complexity makes it a promising candidate for development into a space cold-atom clock, promoting advancements in space science and navigational positioning. Additionally, it possesses great potential to serve as an absolute wavelength standard.
Growing Evidence for the Role of Air Pollution in Breast Cancer Development
Impact of mechanically applied strain on Auger recombination in InGaAs multiple quantum wells
We present the results of direct measurements of the effect of mechanically applied biaxial strain on Auger recombination rates in InGaAs quantum wells grown on InP. By mounting these structures on a flexible membrane, we applied strain mechanically rather than by changing the quantum well alloy fraction. Specifically, we employed time-resolved photoluminescence spectroscopy to probe the recombination dynamics in the degenerate carrier regime. From these measurements, we extract the non-degenerate cubic Auger coefficient C30. We found that applying 1.59% tensile biaxial strain increased the Auger C30 coefficient by 325% in one of our samples. These results support the hypothesis that the mechanical strain induced by heteroepitaxy plays a direct role in mitigating Auger recombination in InP-based telecommunication-range lasers.
Instantaneous self-recovery and ultra-low detection limit hydrogel electronic sensor for temporomandibular disorders intelligent diagnosis
BEOL-compatible Te-TeO<i>x</i> p-FETs with channel length down to 50 nm at cryogenic temperatures
In this work, we present p-type Te-TeOx FETs with BEOL-compatibility targeting high-performance computing at cryogenic temperatures. The devices feature aggressively scaled channel lengths (Lch of 50 nm) deposited using the sputtering method that is cost-effective, large-scale manufacturable, and highly controllable. We investigated the effects of oxygen content and film thickness in the sputtered channel layer on device performance. The device achieves a maximum transconductance (Gm, max) of 142 μS/μm, an on/off ratio exceeding 3 × 108, a subthreshold swing (SS) of 99 mV/Dec., a high hole mobility of 28.6 cm2/V s, and excellent NBTI and PBTI reliability characteristics at 77 K.
Author Correction: Sublimed C60 for efficient and repeatable perovskite-based solar cells
Non-Hermitian photonics: Guest editorial
Bioinspired artificial antioxidases for efficient redox homeostasis and maxillofacial bone regeneration
Abstract Reconstructing large, inflammatory maxillofacial defects using stem cell-based therapy faces challenges from adverse microenvironments, including high levels of reactive oxygen species (ROS), inadequate oxygen, and intensive inflammation. Here, inspired by the reaction mechanisms of intracellular antioxidant defense systems, we propose the de novo design of an artificial antioxidase using Ru-doped layered double hydroxide (Ru-hydroxide) for efficient redox homeostasis and maxillofacial bone regeneration. Our studies demonstrate that Ru-hydroxide consists hydroxyls-synergistic monoatomic Ru centers, which efficiently react with oxygen species and collaborate with hydroxyls for rapid proton and electron transfer, thus exhibiting efficient, broad-spectrum, and robust ROS scavenging performance. Moreover, Ru-hydroxide can effectively sustain stem cell viability and osteogenic differentiation in elevated ROS environments, modulating the inflammatory microenvironment during bone tissue regeneration in male mice. We believe this Ru-hydroxide development offers a promising avenue for designing antioxidase-like materials to treat various inflammation-associated disorders, including arthritis, diabetic wounds, enteritis, and bone fractures.
High-crystallinity and enhanced mobility in In2O3 thin-film transistors via metal-induced method
Meeting the advanced demands of display technology, developing oxide semiconductor thin-film transistors (TFTs) with high mobility remains a significant challenge in current research. This paper reports the fabrication of high-crystallinity In2O3 thin films and high-mobility TFT devices through low-temperature annealing using aluminum (Al) and tantalum (Ta) for induced crystallization. In the control film, partial crystallization occurs only in the central region, with grain lateral dimensions around 50 nm, resulting in a reasonable field-effect mobility of 23.9 cm2/V s for the corresponding TFTs. In contrast, metal-induced films form In2O3 grains with lateral dimensions exceeding 100 nm, along with numerous spherical crystalline particles at the metal/In2O3 interface. The well-defined front-channel structure allows the Al- and Ta-induced In2O3 TFTs to achieve high field-effect mobilities of 65.2 and 101.0 cm2/V s, respectively. Additionally, Al induction improves the subthreshold swing and threshold voltage (Vth), enhancing overall electrical performance. This study investigates the crystallization behavior of induced technology in the In2O3 system, elucidates the mechanism of metal-induced crystallization, and demonstrates that Al-induced crystallization significantly enhances the performance of metal oxide TFTs under processing temperature constraints.
Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils
Significant improvement of energy storage density and efficiency of 0.72Bi0.5Na0.5TiO3-0.28SrTiO3 ceramics and study of the mechanism of high temperature energy storage performance
The energy storage properties of the 0.72Bi0.5Na0.5TiO3-0.28SrTiO3 system have been heavily investigated; however, achieving both high recoverable energy storage density (Wr) and large energy efficiency (η) remains a challenge. In this study, relaxor ferroelectric ceramics exhibiting high Wr and η were prepared by introducing BaSnO3 into 0.9(Bi0.5Na0.5)0.72Sr0.28TiO3-0.1Bi(Mg0.5Ti0.5)O3 relaxor ceramics. A remarkable Wr of 7.5 J/cm3 and η of 91.2% were achieved in the 0.94[0.9(Bi0.5Na0.5)0.72Sr0.28TiO3-0.1Bi(Mg0.5Ti0.5)O3]-0.06BaSnO3 ceramic at an electric field of 460 kV/cm. The η and the energy storage potential (Wr/Eb), respectively, surpass those reported for most ceramics in recent years. The introduction of high-temperature-stable BaSnO3 imparted excellent temperature and frequency stability to the ceramic. The ceramic exhibited a Wr of 3.6 J/cm3 and an η of 79.6% at 160 °C and 265 kV/cm. The sample has a power density of 202.8 MW/cm3, an energy density of 2.2 J/cm3 at an electric field of 260 kV/cm, and a fast charge–discharge capability.